Two novel aquaporin-2 mutations responsible for congenital nephrogenic diabetes insipidus in Chinese families

被引:43
作者
Lin, SH
Bichet, DG
Sasaki, S
Kuwahara, M
Arthus, MF
Lonergan, M
Lin, YF
机构
[1] Univ Montreal, Hop Sacre Coeur, Res Ctr, Dept Med, Montreal, PQ H4J 1C5, Canada
[2] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Med, Div Nephrol, Montreal, PQ, Canada
[3] Tokyo Med & Dent Univ, Tokyo 1138519, Japan
关键词
D O I
10.1210/jc.87.6.2694
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mutations in the aquaporin-2 gene (AQP2), encoding the vasopressin-regulated water channel of the renal collecting duct, are responsible for the autosomal recessive or dominant forms of congenital nephrogenic diabetes insipidus. We describe two new families with normal hypotensive and coagulation responses following the administration of desamino-8-D-arginine AVP, a clinical suggestion of normal vasopressin-2 receptors. The patients were compound heterozygotes for point mutations at nucleotide position 170 (CAG to CCG; Q57P) and at position 299 (GGA to GTA, G100V) in exon 1 of the AQP2 gene. Expression of the G57P and G100V AQP2 proteins in Xenopus oocytes showed only 1.3-fold and 1.2-fold increase, respectively, in the water permeability in contrast to 8.0-fold increase in oocytes injected with wild-type cRNA. Immunoblots of oocyte lysate revealed the intensities of the 29-kDa bands were comparable among oocytes injected with wildtype and mutant cRNAs. Immunocytochemistry showed the plasma membrane was not stained in oocytes injected with cRNA of Q57P and of G100V. These results provide evidence that the Q57P and G100V mutations in congenital nephrogenic diabetes insipidus are attributable to the misrouting of AQP2.
引用
收藏
页码:2694 / 2700
页数:7
相关论文
共 35 条
  • [1] Ala Y, 1998, J AM SOC NEPHROL, V9, P1861
  • [2] Traffic jam: A compendium of human diseases that affect intracellular transport processes
    Aridor, M
    Hannan, LA
    [J]. TRAFFIC, 2000, 1 (11) : 836 - 851
  • [3] Bichet D., 1998, OXFORD TXB CLIN NEPH, P1095
  • [4] Bichet DG, 1997, J AM SOC NEPHROL, V8, P1951
  • [5] EPINEPHRINE AND DDAVP ADMINISTRATION IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS - EVIDENCE FOR A PRE-CYCLIC AMP V2-RECEPTOR DEFECTIVE MECHANISM
    BICHET, DG
    RAZI, M
    ARTHUS, MF
    LONERGAN, M
    TITTLEY, P
    SMILEY, RK
    ROCK, G
    HIRSCH, DJ
    [J]. KIDNEY INTERNATIONAL, 1989, 36 (05) : 859 - 866
  • [6] HEMODYNAMIC AND COAGULATION RESPONSES TO 1-DESAMINO[8-D-ARGININE] VASOPRESSIN IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS
    BICHET, DG
    RAZI, M
    LONERGAN, M
    ARTHUS, MF
    PAPUKNA, V
    KORTAS, C
    BARJON, JN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14) : 881 - 887
  • [7] BICHET DG, 1995, J AM SOC NEPHROL, V6, P717
  • [8] Bichet DG, 2001, METABOLIC MOL BASES, P4181
  • [9] NORMAL RESPONSE OF FACTOR-VIII AND VON-WILLEBRAND FACTOR TO 1-DEAMINO-8D-ARGININE VASOPRESSIN IN NEPHROGENIC DIABETES-INSIPIDUS
    BRENNER, B
    SELIGSOHN, U
    HOCHBERG, Z
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) : 191 - 193
  • [10] Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response
    Canfield, MC
    Tamarappoo, BK
    Moses, AM
    Verkman, AS
    Holtzman, EJ
    [J]. HUMAN MOLECULAR GENETICS, 1997, 6 (11) : 1865 - 1871